NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
Apr 25 04:00PM ET
82.74
Dollar change
+2.90
Percentage change
3.63
%
IndexDJIA, S&P 500 P/E12.05 EPS (ttm)6.87 Insider Own0.09% Shs Outstand2.52B Perf Week6.08%
Market Cap208.21B Forward P/E8.45 EPS next Y9.80 Insider Trans0.04% Shs Float2.51B Perf Month-6.09%
Income17.43B PEG0.99 EPS next Q2.06 Inst Own80.29% Short Float1.67% Perf Quarter-13.41%
Sales63.69B P/S3.27 EPS this Y16.81% Inst Trans1.21% Short Ratio2.37 Perf Half Y-22.41%
Book/sh18.32 P/B4.52 EPS next Y9.61% ROA15.30% Short Interest41.93M Perf Year-34.79%
Cash/sh5.47 P/C15.13 EPS next 5Y12.17% ROE40.81% 52W Range75.93 - 134.63 Perf YTD-16.83%
Dividend Est.3.29 (3.98%) P/FCF11.51 EPS past 5Y12.04% ROI21.35% 52W High-38.54% Beta0.46
Dividend TTM3.16 (3.82%) Quick Ratio1.15 Sales past 5Y7.14% Gross Margin81.82% 52W Low8.97% ATR (14)2.98
Dividend Ex-DateMar 17, 2025 Current Ratio1.36 EPS Y/Y TTM4577.79% Oper. Margin34.72% RSI (14)49.07 Volatility3.61% 3.88%
Employees75000 Debt/Eq0.83 Sales Y/Y TTM4.26% Profit Margin27.37% Recom1.85 Target Price109.63
Option/ShortYes / Yes LT Debt/Eq0.76 EPS Q/Q7.20% Payout46.32% Rel Volume1.57 Prev Close79.84
Sales Surprise1.24% EPS Surprise4.09% Sales Q/Q-1.77% EarningsApr 24 BMO Avg Volume17.73M Price82.74
SMA201.55% SMA50-5.23% SMA200-19.26% Trades Volume27,768,733 Change3.63%
Date Action Analyst Rating Change Price Target Change
Apr-22-25Initiated Cantor Fitzgerald Neutral $85
Feb-18-25Downgrade Deutsche Bank Buy → Hold $128 → $105
Feb-10-25Downgrade TD Cowen Buy → Hold $121 → $100
Jan-08-25Downgrade Truist Buy → Hold $110
Dec-20-24Downgrade BMO Capital Markets Outperform → Market Perform $136 → $105
Dec-10-24Resumed BofA Securities Buy $121
Dec-04-24Upgrade HSBC Securities Hold → Buy $130
Nov-15-24Initiated Wolfe Research Peer Perform
Nov-11-24Downgrade Daiwa Securities Buy → Neutral
Oct-17-24Initiated Bernstein Mkt Perform $115
Today 09:22AM
07:00AM
Apr-26-25 02:32PM
12:50PM
09:30AM
04:00PM Loading…
Apr-25-25 04:00PM
11:57AM
09:25AM
06:34AM
12:49AM
Apr-24-25 05:24PM
04:08PM
02:20PM
02:01PM
02:01PM
01:20PM Loading…
01:20PM
12:05PM
11:22AM
10:30AM
10:19AM
09:37AM
07:43AM
07:40AM
07:07AM
06:59AM
06:40AM
06:30AM
06:30AM
06:30AM
Apr-23-25 07:00PM
04:10PM Loading…
04:10PM
02:50PM
01:08PM
09:25AM
08:02AM
Apr-22-25 09:01PM
09:06AM
07:32AM
07:09AM
07:00AM
Apr-21-25 09:33PM
11:14AM
08:17AM
Apr-20-25 05:52AM
Apr-19-25 11:44AM
11:00AM
11:00AM
11:00AM
Apr-18-25 09:00PM
10:03AM
10:00AM
09:15AM
Apr-17-25 01:13PM
01:06PM
10:01AM
09:55AM
09:00AM
Apr-16-25 04:28PM
02:41PM
01:05PM
12:56PM
09:53AM
Apr-15-25 10:43AM
09:59AM
09:09AM
07:35AM
06:54AM
Apr-14-25 05:50PM
10:37AM
10:29AM
09:08AM
05:57AM
Apr-13-25 05:57PM
02:12PM
09:15AM
Apr-11-25 12:33PM
11:15AM
Apr-10-25 12:58PM
08:55AM
Apr-09-25 06:32PM
03:59PM
10:43AM
10:11AM
10:06AM
09:57AM
03:15AM
Apr-08-25 06:15PM
10:03AM
Apr-07-25 01:46PM
08:37AM
05:10AM
Apr-05-25 08:14AM
08:00AM
Apr-03-25 05:45PM
03:15PM
10:30AM
09:27AM
Apr-02-25 09:43AM
09:30AM
09:14AM
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DALTON SMARTOfficerApr 25 '25Proposed Sale82.764,262352,723Apr 25 04:05 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketFeb 19 '25Sale84.098,500714,74530,705Feb 20 04:01 PM
JOHANNES JACOBUS OOSTHUIZENOfficerFeb 19 '25Proposed Sale84.098,500714,745Feb 19 05:09 PM
DAVID WILLIAMSOfficerFeb 13 '25Proposed Sale85.346,000512,057Feb 13 04:10 PM
Williams David MichaelEVP,Chief Info&Digital OfficerFeb 13 '25Sale85.346,000512,05724,123Feb 13 04:01 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketFeb 08 '25Option Exercise87.2813,0021,134,81545,609Feb 11 02:59 PM
THULIN INGE GDirectorFeb 06 '25Buy88.252,833250,0002,933Feb 07 04:09 PM
Downing Cristal NChief Comm. & Public Afrs OfcrFeb 06 '25Sale88.762,361209,5517,085Feb 07 04:07 PM
BAKER DOUGLAS M JRDirectorFeb 05 '25Buy88.5015,0001,327,50016,000Feb 07 04:04 PM
CRISTAL DOWNINGOfficerFeb 06 '25Proposed Sale88.762,361209,551Feb 06 04:43 PM
Guindo ChirfiChief Marketing OfficerAug 05 '24Option Exercise115.2036,9014,250,99557,782Aug 06 12:20 PM
Smart DaltonSVP Fin. - Global ControllerMay 03 '24Option Exercise128.262,046262,4204,708May 06 04:10 PM
Smart DaltonSVP Fin. - Global ControllerMay 04 '24Option Exercise127.5161278,0364,730May 06 04:10 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthMay 04 '24Option Exercise127.5127,1263,458,836163,720May 06 04:08 PM
Klobuchar Michael AEVP - Chief Strategy OfficerMay 04 '24Option Exercise127.51887113,10124,058May 06 04:06 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketMay 04 '24Option Exercise127.51912116,28924,271May 06 04:01 PM
Romanelli JosephPresident, Human Health Int?lMay 02 '24Option Exercise128.802,262291,34621,831May 02 04:29 PM
Smart DaltonSVP Fin. - Global ControllerMay 02 '24Option Exercise128.8038149,0733,048May 02 04:23 PM